Biomarkers of vascular calcification and mortality in patients with ESRD.
Title | Biomarkers of vascular calcification and mortality in patients with ESRD. |
Publication Type | Journal Article |
Year of Publication | 2014 |
Authors | Scialla JJ, Kao WHLinda, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS |
Journal | Clin J Am Soc Nephrol |
Volume | 9 |
Issue | 4 |
Pagination | 745-55 |
Date Published | 2014 Apr |
ISSN | 1555-905X |
Abstract | BACKGROUND: Vascular calcification is common among patients undergoing dialysis and is associated with mortality. Factors such as osteoprotegerin (OPG), osteopontin (OPN), bone morphogenic protein-7 (BMP-7), and fetuin-A are involved in vascular calcification. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: OPG, OPN, BMP-7, and fetuin-A were measured in blood samples from 602 incident dialysis patients recruited from United States dialysis centers between 1995 and 1998 as part of the Choices for Healthy Outcomes In Caring for ESRD Study. Their association with all-cause and cardiovascular mortality were assessed using Cox proportional hazards models adjusted for demographic characteristics, comorbidity, serum phosphate, and calcium. An interaction with diabetes was tested because of its known association with vascular calcification. Predictive accuracy of selected biomarkers was explored by C-statistics in nested models with training and validation subcohorts. RESULTS: Higher OPG and lower fetuin-A levels were associated with higher mortality over up to 13 years of follow-up (median, 3.4 years). The adjusted hazard ratios (HR) for highest versus lowest tertile were 1.49 (95% confidence interval [95% CI], 1.08 to 2.06) for OPG and 0.69 (95% CI, 0.52 to 0.92) for fetuin-A. In stratified models, the highest tertile of OPG was associated with higher mortality among patients without diabetes (HR, 2.42; 95% CI, 1.35 to 4.34), but not patients with diabetes (HR, 1.26; 95% CI, 0.82 to 1.93; P for interaction=0.001). In terms of cardiovascular mortality, higher fetuin-A was associated with lower risk (HR, 0.85 per 0.1 g/L: 95% CI, 0.75 to 0.96). In patients without diabetes, higher OPG was associated with greater risk (HR for highest versus lowest tertile, 2.91; 95% CI, 1.06 to 7.99), but not in patients with diabetes or overall. OPN and BMP-7 were not independently associated with outcomes overall. The addition of OPG and fetuin-A did not significantly improve predictive accuracy of mortality. CONCLUSIONS: OPG and fetuin-A may be risk factors for all-cause and cardiovascular mortality in patients undergoing dialysis, but do not improve risk prediction. |
DOI | 10.2215/CJN.05450513 |
Alternate Journal | Clin J Am Soc Nephrol |
PubMed ID | 24458076 |
PubMed Central ID | PMC3974354 |
Grant List | 5K01DK067207-05 / DK / NIDDK NIH HHS / United States 5KL2RR025006 / RR / NCRR NIH HHS / United States 5R01DK072367-03 / DK / NIDDK NIH HHS / United States 5U01DK070657-03 / DK / NIDDK NIH HHS / United States K23DK083514 / DK / NIDDK NIH HHS / United States K23DK095949 / DK / NIDDK NIH HHS / United States K24DK02643 / DK / NIDDK NIH HHS / United States R01DK059616 / DK / NIDDK NIH HHS / United States R01DK080123 / DK / NIDDK NIH HHS / United States R01HL62985 / HL / NHLBI NIH HHS / United States R01HS008365 / HS / AHRQ HHS / United States T32DK007732-14 / DK / NIDDK NIH HHS / United States |